Stock CHE CHEMED CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Chemed Corporation

Equities

CHE

US16359R1032

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-17 pm EDT 		5-day change 1st Jan Change
604.2 USD -0.95% Intraday chart for Chemed Corporation -2.64% +3.32%
Apr. 08 Chemed Corporation Receives Shareholders Proposal from John Chevedden CI
Apr. 01 Chemed Insider Sold Shares Worth $1,283,300, According to a Recent SEC Filing MT

Evolution of the average Target Price on Chemed Corporation

Price target over the last 5 years

History of analyst recommendation changes

7f580c.ha79zK1wt7n9ZOFruSDTwFUhe3NVlUHOGmWJiX3VTFU.0dasr8Ij0sOQLpYB0k6auDxNKARlxBKBXDfD2TmlOzPanpWu9BH67ZhWjg~014933baacbfaf67b7a6822448b550a8

Analyst Recommendations on Chemed Corporation

Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing MT
Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing MT
RBC Boosts Price Target on Chemed to $712 From $604, Expects 'Strong' VITAS Momentum to Continue in 2024; Outperform Kept MT
Oppenheimer Raises Chemed Price Target to $650 From $625, Maintains Outperform Rating MT
Oppenheimer Adjusts Chemed Price Target to $625 From $590, Maintains Outperform Rating MT
RBC Raises Price Target on Chemed to $604 From $576, Keeps Outperform Rating MT
RBC Cuts Price Target on Chemed to $576 From $610, Maintains Outperform Rating MT
Oppenheimer Adjusts Chemed Price Target to $590 From $610, Maintains Outperform Rating MT
RBC Boosts Price Target on Chemed to $610 From $587 After 'Solid Results,' Maintains Outperform Rating MT
Oppenheimer Raises Chemed's Price Target to $610 From $580, Maintains Outperform Rating MT
RBC Raises Price Target on Chemed to $587 From $545, Maintains Outperform Rating MT
RBC Raises Price Target on Chemed to $545 From $541, Maintains Outperform Rating MT
RBC Cuts Price Target on Chemed to $541 From $592, Citing Recent Industry Multiple Compression, Maintains Outperform Rating MT
RBC Boosts Price Target on Chemed to $592 From $579, Maintains Outperform Rating MT
RBC Cuts Price Target on Chemed to $579 From $609, Maintains Outperform Rating MT
CHEMED : RBC Boosts Price Target on Chemed to $609 From $604, Citing Strong Roto-Rooter Growth, Maintains Outperform Rating MT
CHEMED : RBC Boosts Price Target on Chemed to $604 From $600, Sees Guidance Raise Likely, Maintains Outperform Rating MT
CHEMED : Oppenheimer Adjusts Chemed PT to $580 From $600, Maintains Outperform Rating MT
CHEMED : Oppenheimer Adjusts Chemed's Price Target to $600 From $535, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
604.2 USD
Average target price
688.8 USD
Spread / Average Target
+14.00%
High Price Target
712 USD
Spread / Highest target
+17.85%
Low Price Target
650 USD
Spread / Lowest Target
+7.59%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Chemed Corporation

RBC Capital Markets
Oppenheimer

Ratings for Chemed Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CHE Stock
  4. Consensus Chemed Corporation